Harrow Inc (HROW)
17.95
+0.11
(+0.62%)
USD |
NASDAQ |
May 31, 16:00
18.09
+0.14
(+0.78%)
After-Hours: 20:00
Harrow Cash from Financing (Quarterly): -0.809M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.809M |
| December 31, 2023 | -0.018M |
| September 30, 2023 | 64.20M |
| June 30, 2023 | 0.189M |
| March 31, 2023 | 62.16M |
| December 31, 2022 | 55.03M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.111M |
| March 31, 2022 | -0.776M |
| December 31, 2021 | -0.002M |
| September 30, 2021 | 0.015M |
| June 30, 2021 | 52.24M |
| March 31, 2021 | -0.781M |
| December 31, 2020 | -0.77M |
| September 30, 2020 | -0.761M |
| June 30, 2020 | 2.966M |
| March 31, 2020 | -0.002M |
| December 31, 2019 | 0.635M |
| September 30, 2019 | -0.413M |
| June 30, 2019 | -0.455M |
| March 31, 2019 | -0.773M |
| December 31, 2018 | 1.411M |
| September 30, 2018 | 2.469M |
| June 30, 2018 | 0.349M |
| March 31, 2018 | -0.098M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.695M |
| September 30, 2017 | 2.123M |
| June 30, 2017 | -0.627M |
| March 31, 2017 | 2.739M |
| December 31, 2016 | 8.893M |
| September 30, 2016 | 1.975M |
| June 30, 2016 | -0.056M |
| March 31, 2016 | 13.86M |
| December 31, 2015 | 0.301M |
| September 30, 2015 | -0.054M |
| June 30, 2015 | 10.50M |
| March 31, 2015 | -0.005M |
| December 31, 2014 | -0.018M |
| September 30, 2014 | 0.134M |
| June 30, 2014 | 0.134M |
| March 31, 2014 | 0.349M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 10.05M |
| December 31, 2012 | -0.3414M |
| September 30, 2012 | 3.943M |
| June 30, 2012 | 7.854M |
| March 31, 2012 | 0.35M |
| December 31, 2011 | 0.1183M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.809M
Minimum
Mar 2024
64.20M
Maximum
Sep 2023
11.63M
Average
-0.002M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Durect Corp | -1.495M |
| Aquestive Therapeutics Inc | 81.74M |
| Cyclacel Pharmaceuticals Inc | -0.079M |
| Stereotaxis Inc | 0.03M |
| Cara Therapeutics Inc | -0.685M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.628M |
| Cash from Investing (Quarterly) | -0.11M |
| Free Cash Flow | -14.27M |
| Free Cash Flow Per Share (Quarterly) | -0.1336 |
| Free Cash Flow to Equity (Quarterly) | -5.714M |
| Free Cash Flow to Firm (Quarterly) | 0.677M |
| Free Cash Flow Yield | -2.34% |